GGDPX
Price
$15.76
Change
-$0.04 (-0.25%)
Updated
Jul 25 closing price
Net Assets
5.26B
TTISX
Price
$13.18
Change
-$0.04 (-0.30%)
Updated
Jul 25 closing price
Net Assets
1.28B
Interact to see
Advertisement

GGDPX vs TTISX

Header iconGGDPX vs TTISX Comparison
Open Charts GGDPX vs TTISXBanner chart's image
Goldman Sachs Intl Sm Cp Insghts P
Price$15.76
Change-$0.04 (-0.25%)
VolumeN/A
Net Assets5.26B
Nuveen Quant Intl Sm Cap Eq Retirement
Price$13.18
Change-$0.04 (-0.30%)
VolumeN/A
Net Assets1.28B
GGDPX vs TTISX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GGDPX vs. TTISX commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGDPX is a Buy and TTISX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GGDPX has more cash in the bank: 5.26B vs. TTISX (1.28B). GGDPX pays higher dividends than TTISX: GGDPX (3.78) vs TTISX (2.42). GGDPX was incepted earlier than TTISX: GGDPX (7 years) vs TTISX (9 years). TTISX (0.98) is less costly to investors than GGDPX (0.90). GGDPX is a more actively managed with annual turnover of: 165.00 vs. TTISX (114.00). GGDPX (0) and TTISX (0) have matching initial minimum investment requirements. GGDPX annual gain was more profitable for investors over the last year : 27.14 vs. TTISX (23.83). GGDPX return over 5 years is better than : 70.56 vs. TTISX (59.29).
GGDPXTTISXGGDPX / TTISX
Total Expense Ratio0.850.9887%
Annual Report Gross Expense Ratio0.900.9892%
Fund Existence7 years9 years-
Gain YTD28.23425.763110%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets5.26B1.28B412%
Annual Yield % from dividends3.782.42157%
Returns for 1 year27.1423.83114%
Returns for 3 years58.7651.41114%
Returns for 5 years70.5659.29119%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MEDXF2.070.03
+1.42%
Medexus Pharmaceuticals Inc
CLPXY9.150.07
+0.82%
China Longyuan Power Group
AVCVF0.07N/A
N/A
Monitor Ventures Inc.
AGMJF11.84N/A
N/A
Algoma Central Corp.
YMZBY180.00N/A
N/A
Yamazaki Baking Co. Ltd.